Page last updated: 2024-08-23

paclitaxel and Superior Vena Cava Obstruction

paclitaxel has been researched along with Superior Vena Cava Obstruction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asai, M; Iwahori, K; Komuta, K; Minami, S1

Other Studies

1 other study(ies) available for paclitaxel and Superior Vena Cava Obstruction

ArticleYear
[A case of adenocarcinoma of the lung with superior vena cava syndrome (SVCS), effectively treated with implantation of intravascular stent and chemotherapy of single agent of docetaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Middle Aged; Paclitaxel; Stents; Superior Vena Cava Syndrome; Taxoids

2002